Pfizer Inc.

NYSE: PFE · Real-Time Price · USD
25.09
-0.02 (-0.08%)
At close: Aug 15, 2025, 12:30 PM

Pfizer Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
8.05B 2.17B 31.4B 22.46B
Depreciation & Amortization
7.01B 6.29B 5.06B 5.19B
Stock-Based Compensation
877M 525M 872M 1.18B
Other Working Capital
-1.08B -8.42B -6.5B 16.5B
Other Non-Cash Items
1.97B 5.33B 150M -4.76B
Deferred Income Tax
-2.1B -3.44B -3.76B -4.29B
Change in Working Capital
-3.07B -2.17B -4.46B 12.8B
Operating Cash Flow
12.74B 8.7B 29.27B 32.58B
Capital Expenditures
-2.91B -3.91B -3.24B -2.71B
Cash Acquisitions
7.04B -43.43B -23B -12M
Purchase of Investments
-10.31B -31.18B -38.78B -47.61B
Sales Maturities Of Investments
8.83B 46.42B 45.46B 28.1B
Other Investing Acitivies
n/a -180M 3.77B -306M
Investing Cash Flow
2.65B -32.28B -15.78B -22.55B
Debt Repayment
-7.16B 35.95B -3.52B -1.1B
Common Stock Repurchased
n/a n/a -2B n/a
Dividend Paid
-9.51B -9.25B -8.98B -8.73B
Other Financial Acitivies
-469M -632M -335M 16M
Financial Cash Flow
-17.14B 26.07B -14.83B -9.82B
Net Cash Flow
-1.81B 2.45B -1.51B 158M
Free Cash Flow
9.84B 4.79B 26.03B 29.87B